source
- Thermo Fisher to divest microbiology unit to Astorg for $1.075 billion; Ligand announces purchase of XOMAThermo Fisher Scientific announced it will sell its microbiology business, part of its specialty diagnostics segment, to European private‑equity firm Astorg. The transaction is valued at $1.075 bi…
- Oruka Therapeutics reports Phase 2 psoriasis results with 63% of patients showing plaque improvementOruka Therapeutics announced results from its Phase 2 trial in moderate to severe plaque psoriasis. The study enrolled 63 patients and 40 of them, about 63.5%, achieved the predefined level of ski…